Skip to main content

Security report for bioqubeventures.com

Bioqube Ventures · Healthcare · N/a

Medium risk. 6 critical or high findings in Security headers, GDPR outside view and 1 other check.

Security score

65/100

Risk levelMedium

0–100, higher is better. How it is calculated

Bioqube Ventures is a specialist life sciences venture capital firm operating primarily in Europe and the US, focusing on investing in innovative therapeutic assets and technologies. Their business model includes both classical investment rounds and venture creation projects, leveraging in-house expertise to translate scientific innovation into commercial ventures. The website presents a professional image with clear messaging targeting investors and biotech entrepreneurs. Technically, the site is built on WordPress using modern frameworks and plugins, with good SEO and mobile optimization. Security posture is solid with HTTPS and no visible vulnerabilities, though some security headers and privacy mechanisms could be improved. The absence of WHOIS data is a notable concern, reducing trust in domain legitimacy despite the professional web presence. Overall, the site is credible but would benefit from enhanced transparency and compliance features.

Scanned

NIS2 and GDPR posture

GDPR outside view
53/ 100 · Medium
Checks completed
7of 7

NIS2 Art. 21(2)

  1. (a) Risk analysis and security policies: Not visible from outside
  2. (b) Incident handling: One indicator
  3. (c) Business continuity, backups and crisis management: Not visible from outside
  4. (d) Supply chain security: Not visible from outside
  5. (e) Secure acquisition, development and maintenance, including vulnerability handling: Partly checked
  6. (f) Assessing the effectiveness of security measures: Not visible from outside
  7. (g) Cyber hygiene and security training: Not visible from outside
  8. (h) Cryptography and encryption: Partly checked
  9. (i) HR security, access control and asset management: One indicator
  10. (j) Multi-factor authentication and secured communications: Not visible from outside

This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.

GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.

Priority findings

6 findings rated critical or high. Fix these first.

  1. Security headers

    Security headers are instructions your web server sends to every visitor’s browser. Missing ones leave visitors more exposed to attacks such as clickjacking and injected scripts.

    • High

      Missing Strict-Transport-Security header

      Forces HTTPS connections

      What to do: Add "Strict-Transport-Security: max-age=31536000; includeSubDomains; preload"

      • CWE-319
      • OWASP A04:2025
      • ASVS V3.4.1
    • High

      Missing X-Frame-Options header

      Prevents clickjacking attacks

      What to do: Add "X-Frame-Options: DENY" or "X-Frame-Options: SAMEORIGIN"

    • High

      Missing Content-Security-Policy header

      Controls resources the browser is allowed to load

      What to do: Implement a Content-Security-Policy appropriate for your application

      • ASVS V3.4.3
      • OWASP Secure Headers: OWASP Secure Headers Project recommends Content-Security-Policy: default-src 'self'; form-action 'self'; base-uri 'self'; object-src 'none';…

  2. GDPR outside view

    These are the privacy signals visitors and data protection authorities look for under GDPR.

    • High

      No Cookie Policy found

      GDPR requires clear information about cookie usage

      What to do: Add a dedicated cookie policy explaining cookie usage and purposes

    • High

      No Cookie Consent Banner found

      GDPR requires explicit consent for non-essential cookies

      What to do: Implement a cookie consent banner that appears on first visit

Need hands-on remediation? Email guard@offseq.com

Keep watching bioqubeventures.com

This scan found 26 issues across 6 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.

Daily monitoring

Recommended

€25per month

  • TLS certificates and expiry
  • DNS records
  • SPF, DKIM and DMARC
  • Security headers
  • GDPR and NIS2 posture
  • Exposed services
  • Third-party trackers
  • Security score drift

Email alerts on material changes and an exportable JSON history of every change.

Billed monthly to your card. Cancel anytime. The full timeline opens with your unlock code.

Full report

€39.90one-time

  • The complete analysis as a PDF you can cite
  • Email delivery with an unlock code
  • Lifetime access to this report

Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.

Results by check

Each check with its score, findings and the evidence it collected.

How this score is calculated

The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.

Counted in this score

SSL/TLS
62
Security headers
30
Email security
85
DNS health
60
Network security
100
GDPR outside view
53
Average
65

Not counted

  • NIS2 outside view: Re-weights evidence from the TLS, email, DNS, network and hygiene checks, so counting it would count that evidence twice. Shown on its own.
  • OffSeq Observations: An AI reading of the site, useful context but not reproducible evidence. Shown on its own.

Findings that cap the score at 49

Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.

  • The certificate is not trusted by browsers
  • The website is not served over HTTPS
  • A database, remote desktop, file-sharing or Telnet service is reachable from the internet
  • The page loads a script from a compromised source
  • The domain registration has expired
  • SPF authorises every server to send mail as the domain

Partial scans

When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.

Risk levels

  • Critical0–25
  • High26–49
  • Medium50–75
  • Low76–100

Technical appendix

Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.

Business context

Business profile

The company positions itself as a niche player in the healthcare venture capital sector, with a dual investment approach that differentiates it from traditional funds. Their portfolio and news updates indicate active engagement in the biotech ecosystem. The partnership with InnovFin Equity and EU funding programs adds credibility and financial backing. The investor portal integration suggests a mature operational setup. However, the lack of explicit contact details and company registration information on the site limits direct engagement opportunities. The LinkedIn presence supports networking and brand visibility. Strategic growth appears focused on venture creation and de-risking scientific innovation, targeting breakthrough therapies.

Security posture

The website enforces HTTPS and uses reputable plugins and frameworks, minimizing common web vulnerabilities. No sensitive data or credentials are exposed in the HTML. However, the absence of key security headers like Content-Security-Policy and missing incident response contacts or vulnerability disclosure policies indicate room for improvement. Privacy compliance is partial, with a privacy policy present but no cookie consent mechanism detected. The WHOIS data absence raises questions about domain registration transparency, which could be a risk factor. Overall, the security maturity is moderate to good but should be enhanced to meet best practices and regulatory requirements fully.

Recommendations

  1. Implement a cookie consent banner to comply with GDPR and enhance user privacy transparency.
  2. Add security headers such as Content-Security-Policy, X-Content-Type-Options, and X-Frame-Options to strengthen defense against common web attacks.
  3. Publish an incident response page with security contact information to improve trust and readiness.
  4. Create and link a terms of service page to clarify legal terms and user agreements.
  5. Investigate and resolve the missing WHOIS data issue to improve domain legitimacy and trust.
Site observations

Automated reading of the public site. Ratings are indicative.

Business

Company
Bioqube Ventures
Description
Bioqube Ventures is a specialist life sciences investment firm based in Europe and US with a global footprint. They source, finance and develop innovative therapeutic assets and technologies. They focus on venture creation to translate and de-risk scientific innovation, advancing their investment portfolio and maximizing value for investors.
Key services
investment in therapeutic innovations, venture creation projects, fund management, portfolio development
Content quality
good
Branding
consistent

Technology

Stack
WordPress, Yoast SEO plugin, Google Analytics (MonsterInsights), jQuery, Foundation CSS framework, FontAwesome icons
Frameworks
Foundation 6.5.1
Platforms
WordPress
Performance
moderate
Mobile
good
Accessibility
basic
SEO
good

Security

Observed score
85/100
Good practices seen
  • HTTPS enforced
  • No exposed sensitive data in HTML
  • No visible vulnerable libraries

Analytics and tracking

Services
Google Analytics
Tracking level
moderate
Privacy practices
basic

Advertising

Marketing tools
MonsterInsights Google Analytics plugin
Transparency
basic

Site quality

Design
good
User experience
good
Content relevance
good
Navigation
good
Professionalism
good
Trustworthiness
high

Key observations

  1. Website is fully accessible with no blocking or WAF challenges
  2. Professional life sciences venture capital firm website
  3. No contact emails or phone numbers explicitly listed on homepage
  4. Privacy policy present but no cookie consent banner detected
  5. No terms of service or explicit security policy pages found
  6. Uses modern web technologies and SEO best practices
  7. WHOIS data missing or domain not found in registry, which is suspicious
  8. LinkedIn social media presence confirmed
  9. No signs of adult or questionable content
Technical notes

Notes

The website uses WordPress CMS with Foundation CSS framework and FontAwesome icons, indicating a modern and flexible technical stack. SEO is enhanced via Yoast plugin, and Google Analytics is integrated through MonsterInsights. The site loads JavaScript libraries asynchronously and uses responsive design principles for mobile optimization. Performance is moderate, with no major blocking scripts detected. Accessibility is basic but could be improved with ARIA roles and semantic HTML enhancements. The hosting provider is not explicitly identified. Overall, the technical implementation supports a professional user experience but could benefit from performance tuning and accessibility improvements.
Standards and sources

Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.

Retrieved 2026-10-25

Reviews of this site

Share your experience with bioqubeventures.com. Every review is verified by email and published after moderation.

Overall rating
Select a rating
4000 characters remaining

We’ll email you to confirm your review and keep your details private.

Community rating

No published reviews yet. Be the first to review bioqubeventures.com.

Feedback on this report

Rate this report, add an optional comment, and tell us if you want a security specialist to follow up.

Overall report quality
Select a rating
2000 characters remaining

We only use your feedback to improve Guard reports. Contact details are never shared.